#1713

Madeleine Grogg

Switzerland

Overview

Source of Wealth
Pharmaceuticals
Industry
Healthcare
Residence
Hergiswil

Assets

  • Bachem Holding
    21,862,000 shares @ -
    -
    BANB-CH
  • Burkhalter
    755,000 shares @ -
    -
    BRKN-CH
  • DOTTIKON ES HOLDING
    492,000 shares @ -
    -
    DESN-CH

Biography

Madeleine Grogg is the widow of Peter Grogg, founder of Swiss biochemical company Bachem Holding AG.

Peter Grogg, who died in 2025, started the business in 1971 and served as CEO until 2002, and chairman until 2012.

Grogg and her two billionaire daughters all serve on the board of the family's asset management firm Ingro Finanz AG.

Bachem AG develops and manufactures active pharmaceutical ingredients, including peptides, amino acid derivatives and other organic molecules.

The family controls about 58% of Bachem as well as shares in Swiss electrical engineering company Burkhalter Holding and chemical maker Dottikon.

About

In 1971, Grogg started Bachem with 50,000 Swiss Francs.